Exelixis (EXEL) Tops Q1 EPS by 1c

Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.16, $0.01 better than the analyst estimate of $0.15. Revenue for the quarter came in at $408.8 million versus the consensus estimate of $422.66 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01
• Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c